Article
Clinical applications and perspectives of circulating tumor DNA in gastric cancer
6 Jan 2024
Abstract excerpt
Gastric cancer remains a leading cause of cancer-related death worldwide, largely due to inadequate screening methods, late diagnosis, and limited treatment options. Liquid biopsy has emerged as a promising non-invasive approach for cancer screening and prognosis by detecting circulating tumor components like circulating tumor DNA (ctDNA) in the blood. Numerous gastric cancer-specific ctDNA biomarkers have now...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
